From Anthropic · · 2m
Anthropic Accelerates Drug Development with Claude
Anthropic partners with six biotech firms to use AI for faster drug discovery and clinical trials.
In brief
Anthropic partners with six biotech firms to use AI for faster drug discovery and clinical trials. Anthropic's Claude AI helps six biotech companies develop new medicines faster, including treatments for rare diseases and cancer. Originally reported by Anthropic.
Case studies
Anthropic’s life sciences team partners with six organizations developing new medicines: BigHat Biosciences, Bristol Myers Squibb, Divergence Labs, Enveda, Generate Biomedicines, and The Column Group.
Drug development tasks
Developing a drug involves early research, molecule design, optimization, regulatory filings, clinical trials, and more.
Claude's role
Anthropic uses Claude to support drug development across multiple disease areas and stages of development.
Generate Biomedicines
Generate Biomedicines used Claude Code to shorten CAR T-cell therapy genetic instructions by 70%, creating more effective cancer treatments.
Divergence Labs
Divergence Labs generated 35,000 antibody designs in a month using Claude to treat food allergies.
BigHat Biosciences
BigHat Biosciences improved drug leads with Claude, increasing binding strength 10x and stability 18°C higher.
Enveda
Enveda reduced human review time by 89% using Claude to flag issues in regulatory documents.
The Column Group
The Column Group uses Claude to create Pleiades, a new company for more complex drug programs.
Bristol Myers Squibb
Bristol Myers Squibb uses Claude to assess early-stage drug trial plans and success likelihood.
Mithril Medicine
Mithril Medicine used Claude to advance rare muscular dystrophy treatments from idea to mouse results in 18 months.
Next steps
Anthropic plans to expand Claude's role in clinical trials and share models with life science researchers.
Claude Science
Anthropic launched Claude Science, an AI workbench for researchers, and provides credits for life scientists.
Life Sciences Verification Program
Anthropic created a program to allow trusted organizations to use Claude with permissive safeguards.
Future work
Anthropic aims to partner with more organizations to accelerate drug discovery using AI.
What to remember
Anthropic's Claude AI helps six biotech companies develop new medicines faster, including treatments for rare diseases and cancer.
